0001661318-16-000002.txt : 20161223 0001661318-16-000002.hdr.sgml : 20161223 20161223111117 ACCESSION NUMBER: 0001661318-16-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20161223 DATE AS OF CHANGE: 20161223 EFFECTIVENESS DATE: 20161223 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Health Catalyst Capital, L.P. CENTRAL INDEX KEY: 0001661318 IRS NUMBER: 810696850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-254056 FILM NUMBER: 162068235 BUSINESS ADDRESS: STREET 1: 767 FIFTH AVENUE STREET 2: 18TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10153 BUSINESS PHONE: 212-203-8997 MAIL ADDRESS: STREET 1: 767 FIFTH AVENUE STREET 2: 18TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10153 D/A 1 primary_doc.xml X0707 D/A LIVE 0001661318 Health Catalyst Capital, L.P. 767 FIFTH AVENUE 18TH FLOOR NEW YORK NY NEW YORK 10153 212-203-8997 DELAWARE None None Limited Partnership true 2015 N/A Health Catalyst Associates, LLC 767 Fifth Avenue 18th Floor New York NY NEW YORK 10153 Director General Partner of the Issuer Charles Boorady 767 Fifth Avenue 18th Floor New York NY NEW YORK 10153 Executive Officer Daniel Ross 767 Fifth Avenue 18th Floor New York NY NEW YORK 10153 Executive Officer Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.1 true 0001661318-15-000001 2015-12-14 true true false 0 100000000 27788945 72211055 An additional $37 million has been sold subject to satisfaction of certain conditions. false 1 0 0 0 true A fee for management services calculated quarterly and based on a percentage of commitments will be paid to an affiliate of the Issuer. false Health Catalyst Capital, L.P. /s/ Charles Boorady Charles Boorady Founding Managing Director 2016-12-23